Anti-clotting drug lowers risks in acute coronary syndrome treatment

An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.

Read the whole article on Physorg

More from Physorg